Contact
searchSearch
HMP Global

Gout News

Research Highlights
Nearly Half of Patients With Gout Have Metabolic Syndrome
03/18/2026
Jessica Garlewicz
Recent analysis underscores the need for broader cardiometabolic assessment in gout management and reinforce gout as a multisystem disease.
Recent analysis underscores the need for broader cardiometabolic assessment in gout management and reinforce gout as a multisystem disease.
Recent analysis underscores the...
03/18/2026
Rheumatology & Arthritis
Research Review
Gout and Psoriatic Disease Overlap Presents Diagnostic and Management Challenges
02/17/2026
Jessica Garlewicz
The coexistence of gout and psoriatic disease (PD) is increasingly recognized in clinical practice, with overlapping phenotypes and shared comorbidities complicating diagnosis and treatment decisions.
The coexistence of gout and psoriatic disease (PD) is increasingly recognized in clinical practice, with overlapping phenotypes and shared comorbidities complicating diagnosis and treatment decisions.
The coexistence of gout and...
02/17/2026
Rheumatology & Arthritis
Research Highlights
Achieving Serum Urate Target Linked to Lower Cardiovascular Risk in Gout
02/17/2026
Jessica Garlewicz
Patients with gout who achieved serum urate levels below 6 mg/dL within 12 months of starting urate-lowering therapy (ULT) had a lower 5-year risk of major adverse cardiovascular events compared with those who did not reach target, according...
Patients with gout who achieved serum urate levels below 6 mg/dL within 12 months of starting urate-lowering therapy (ULT) had a lower 5-year risk of major adverse cardiovascular events compared with those who did not reach target, according...
Patients with gout who achieved...
02/17/2026
Rheumatology & Arthritis
Research Summary
Gout Associated With Higher Risk of Long-Term Opioid Use in Veterans Cohort
02/13/2026
Jessica Garlewicz
Patients with gout are significantly more likely to receive long-term opioid prescriptions compared with individuals without gout, according to a large matched cohort study using national Veterans Health Administration data.
Patients with gout are significantly more likely to receive long-term opioid prescriptions compared with individuals without gout, according to a large matched cohort study using national Veterans Health Administration data.
Patients with gout are...
02/13/2026
Rheumatology & Arthritis
News
Treat-to-Target Urate-Lowering Therapy Improves Quality of Life in Gout
02/13/2026
Jessica Garlewicz
The findings provide patient-centered evidence supporting guideline-recommended, protocolized gout management.
The findings provide patient-centered evidence supporting guideline-recommended, protocolized gout management.
The findings provide...
02/13/2026
Rheumatology & Arthritis
Research Highlights
Emerging Microbiome Insights Suggest Novel Adjunct Targets in Gout Management
01/14/2026
Jessica Garlewicz
Growing evidence links alterations in the intestinal microbiome to hyperuricemia and gout, raising interest in whether microbiome-targeted strategies could complement established urate-lowering therapies.
Growing evidence links alterations in the intestinal microbiome to hyperuricemia and gout, raising interest in whether microbiome-targeted strategies could complement established urate-lowering therapies.
Growing evidence links...
01/14/2026
Rheumatology & Arthritis
News
Febuxostat Linked to Higher Hepatotoxicity Risk Than Benzbromarone in Gout Patients
09/15/2025
Riya Gandhi, MA
A propensity score–matched cohort study reveals that febuxostat use carries a significantly higher risk of liver enzyme abnormalities than benzbromarone, particularly among patients with pre-existing liver function elevations.
A propensity score–matched cohort study reveals that febuxostat use carries a significantly higher risk of liver enzyme abnormalities than benzbromarone, particularly among patients with pre-existing liver function elevations.
A propensity score–matched...
09/15/2025
Rheumatology & Arthritis
News
Colchicine Drug Levels Not Predictive of Efficacy or Side Effects in Gout Flare Prevention
09/15/2025
Riya Gandhi, MA
A post hoc analysis of a randomized clinical trial finds no consistent link between plasma colchicine concentrations and flare prevention or adverse effects—challenging the utility of therapeutic drug monitoring in routine gout care.
A post hoc analysis of a randomized clinical trial finds no consistent link between plasma colchicine concentrations and flare prevention or adverse effects—challenging the utility of therapeutic drug monitoring in routine gout care.
A post hoc analysis of a...
09/15/2025
Rheumatology & Arthritis
Research Highlights
Only One-Third of Gout Flare Patients Follow Up After ED Visit, Study Finds
09/15/2025
Riya Gandhi, MA
New research identifies social and clinical factors—such as marital status, age, and colchicine use—that may influence whether patients seek outpatient care after visiting the emergency department for a gout flare.
New research identifies social and clinical factors—such as marital status, age, and colchicine use—that may influence whether patients seek outpatient care after visiting the emergency department for a gout flare.
New research identifies social...
09/15/2025
Rheumatology & Arthritis
News
Time Trends and Predictors of Gout Remission
09/04/2025
Rebecca Mashaw
Gout remission rates steadily increase to 63% by year 6 on urate-lowering therapy, with odds of remission affected by age, race, comorbidities, disease severity, and choice of treatment.
Gout remission rates steadily increase to 63% by year 6 on urate-lowering therapy, with odds of remission affected by age, race, comorbidities, disease severity, and choice of treatment.
Gout remission rates steadily...
09/04/2025
Rheumatology & Arthritis

Popular Articles

News
Relations Between Clinical Response Criteria and Disease Activity Levels With Axial Spondyloarthritis
05/14/2024
Jessica Garlewicz
Researchers aimed to evaluate how achieving different levels of clinical response or disease activity in patients with nonradiographic (nr-) and radiographic (r-) axial spondyloarthritis.
Researchers aimed to evaluate how achieving different levels of clinical response or disease activity in patients with nonradiographic (nr-) and radiographic (r-) axial spondyloarthritis.
Researchers aimed to evaluate...
05/14/2024
Rheumatology & Arthritis
News
ASAS Issues Consensus Recommendations for Imaging in axSpA
10/10/2024
Rebecca Mashaw
Task force produces guidelines focusing on critical elements to help enhance diagnosis and patient care in axial spondyloarthritis.
Task force produces guidelines focusing on critical elements to help enhance diagnosis and patient care in axial spondyloarthritis.
Task force produces guidelines...
10/10/2024
Rheumatology & Arthritis
News
Start-Low Go-Slow Dose Escalation of Allopurinol
07/12/2024
Jessica Garlewicz
Researchers identified which patients with gout may require longer periods of prophylaxis when initiating treatment.
Researchers identified which patients with gout may require longer periods of prophylaxis when initiating treatment.
Researchers identified which...
07/12/2024
Rheumatology & Arthritis
News
Reader Experience, Image Type Affects Diagnostic Accuracy in axSpA Imaging
09/03/2024
Jolynn Tumolo
The most experienced readers showed the highest diagnostic performance in reviewing computed tomography or magnetic resonance imaging when diagnosing axial spondyloarthritis.
The most experienced readers showed the highest diagnostic performance in reviewing computed tomography or magnetic resonance imaging when diagnosing axial spondyloarthritis.
The most experienced readers...
09/03/2024
Rheumatology & Arthritis
News
Diagnosing axSpA in Patients With Chronic Back Pain
05/22/2024
Jessica Garlewicz
In 30% of patients, uncertainty about the diagnosis of axial spondyloarthritis can remain after 2 years of follow-up.
In 30% of patients, uncertainty about the diagnosis of axial spondyloarthritis can remain after 2 years of follow-up.
In 30% of patients, uncertainty...
05/22/2024
Rheumatology & Arthritis

Partner Spotlight

Axial Involvement in SpA: A Patient-Centered Exploration, Chapter 1
SPONSORED
Axial Involvement in SpA, Chapter 1
04/26/2022
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses 3 of his patient cases to identify and differentiate axial involvement within the spectrum of SpA.
Ethan Craig, MD, MPH, discusses...
04/26/2022
Rheumatology & Arthritis

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use